Home Stocks Tasman Metals Takes a Dive Midday After Ending Merger Negotiations

Tasman Metals Takes a Dive Midday After Ending Merger Negotiations

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

Galectin Therapeutics Inc. (NASDAQ:GALT), FireEye Inc (NASDAQ:FEYE) and Hansen Medical, Inc. (NASDAQ:HNSN) 6.06% are this Tuesday’s top gainers midday. The losers are Tasman Metals Ltd (NYSEMKT:TAS), International Tower Hill Mines Ltd (NYSEMKT:THM) and Intrexon Corp (NYSE:XON).

Drug Developer Galectin Surges

Surging +6.85%, today’s top midday gainer is Galectin Therapeutics Inc. (NASDAQ:GALT). The drug developer missed the mark with its results release last Tuesday but is apparently making a comeback. Billionaire George Soros initiated a position in the company in Q1.

Network security company FireEye Inc (NASDAQ:FEYE) jumped +6.36% ahead of its lock-up expiration tomorrow, with which 92 million shares are expected to become available. Tiger Global has maintained a position in the company across two quarters.

The share price of Hansen Medical, Inc. (NASDAQ:HNSN), another Soros Q1 buy, surged +6.06% midday. The firm appointed a new CEO at the start of the month and has also experienced a handful of insider purchases. Today, Cowen and Company lowered its target price to $2.50.

Tasman Metals Dips

Tasman Metals Ltd (NYSEMKT:TAS) dipped -8.65% today after agreeing to end merger negotiations with Flinders Resources Limited. George Soros has maintained a 1.6-million share position in the company across several quarters.

Down -6.25% midday today, International Tower Hill Mines Ltd (NYSEMKT:THM) takes the second spot on today’s list of losers. The John Paulsonpick is still up a solid +51.22% in 2014.

Intrexon Corp (NYSE:XON) slipped -6.12%. In the portfolios of billionaires investors David Einhorn and Daniel Loeb, the biotech company experienced a share price surge late last week but has struggled this year and is down -29.24% YTD.

 

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...